Previous 10 | Next 10 |
IceCure Medical Announces Receipt of Nasdaq Minimum Bid Price Notification PR Newswire CAESAREA, Israel , Nov. 3, 2023 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure" or the "Company"), a developer of the ProSense® System, a minimally-invasive...
IceCure's ICE3 Trial Results Demonstrating 96.91% Recurrence Free Rate Featured in a Presentation at BISICON 2023 in India PR Newswire ICE3 trial will be finalized in Q1 2024 IceCure's distributor in India , Novomed, exhibited ProSense® and received a ...
Independent Scientific Paper by Doctors Using IceCure's ProSense® Published in Journal of Breast Imaging Presents Advantages of Cryoablation Breast Conserving Over Surgery in Early Breast Cancer Patients PR Newswire Paper cites IceCure's ICE3 interim clinical study resu...
2023-10-09 13:00:03 ET More on InMode, Nano-X, etc. Full Of Potential Red Flags: Breaking Down Nano-X Imaging Nano-X Imaging: Cash Burn Makes It A Hold InMode: Bullish Support Failed To Materialize War between Israel and Hamas pushes U.S.-traded Israeli stock...
2023-10-06 15:43:10 ET DENVER, Colo., Oct 6, 2023 ( www.247marketnews.com )- The following companies were among the listings that we covered this week; IceCure Medical Ltd. (NASDAQ: ICCM), Femasys (NASDAQ: FEMY), SeaStar Medical Holding (NASDAQ: ICU), Siyata Mobile (NASDAQ: SYTA), Vivos...
2023-10-05 12:21:19 ET DENVER, Colo., Oct 5, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; IceCure Medical Ltd. (NASDAQ: ICCM), Grom Social Enterprises (NASDAQ: GROM), Euronav (NYSE: EURN), Maiso...
2023-10-05 10:10:30 ET DENVER, Colo., Oct 5, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; IceCure Medical Ltd. (NASDAQ: ICCM), VS Media Holdings (NASDAQ: VSME), Vivos Therapeutics (NASDAQ: VVOS), Femas...
Women Deemed Inoperable for Breast Cancer Benefitted from IceCure Medical's ProSense as an Independent Study Performed in Italy Showed a Tumor Reduction Rate of 93.43% to 96.81% PR Newswire Disappearance of lesions and absence of residual malignant cells in Luminal-A ...
2023-10-02 12:50:19 ET DENVER, Colo., Oct 2, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Icecure Medical Ltd (NASDAQ: ICCM), Femasys (NASDAQ: FEMY), AERWINS Technologies (NASDAQ: AWIN), Momentu...
2023-10-02 10:04:07 ET DENVER, Colo., Oct 2, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Icecure Medical Ltd (NASDAQ: ICCM), Femasys (NASDAQ: FEMY), AERWINS Technologies (NASDAQ: AWIN), Invitae (NYSE:...
News, Short Squeeze, Breakout and More Instantly...
99.74% Recurrence Free Rate for Women with Breast Cancer Treated with IceCure's ProSense® Cryoablation System: Key Findings Delivered at 32nd Annual Meeting of the Japanese Breast Cancer Society PR Newswire Demand for minimally invasive breast cancer treatment was ove...
European Study Provides More Evidence Supporting IceCure's ProSense® is Safe & Effective Cryoablation Treatment for Metastatic and Recurrent Breast Cancer European Study Provides More Evidence Supporting IceCure's ProSense® is Safe & Effective Cryoablation Treatment fo...
U.S. Food and Drug Administration Grants Regulatory Clearance to IceCure for Next-Gen XSense™ Cryoablation System with CryoProbes PR Newswire CAESAREA, Israel , July 1, 2024 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medic...